Episode 442: Are biosimilars similar to biologics for inflammatory conditions?
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer.
Show notes
Tools for Practice
It’s all in the details… or is it? Biosimilars versus biologics for inflammatory conditions
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
